Addendum: Early triage of critically ill COVID-19 patients using deep learning

Wenhua Liang, Jianhua Yao, Ailan Chen, Qingquan Lv, Mark Zanin, Jun Liu, Sook‐San Wong, Yimin Li, Jiatao Lu, Hengrui Liang, Guoqiang Chen, Haiyan Guo, Jun Guo, Rong Zhou, Limin Ou, Niyun Zhou, Hanbo Chen, Fan Yang, Xiao Han, Wenjing Huan, Weimin Tang, Wei‐jie Guan, Zisheng Chen, Yi Zhao, Ling Sang, Yuanda Xu, Wei Wang, Shiyue Li, Ligong Lu, Nuofu Zhang, Nanshan Zhong, Junzhou Huang, Jianxing HeNature Communications 2021 · DOI · OpenAlex

Abstract

The original Article did not reference our previous study, which also presents a clinical prediction model for COVID-19 mortality/critical illness risk. We wish to clarify the similarities and differences between the two studies in terms of cohort populations, methodology, and clinical use.

Introduction

Early in the COVID-19 pandemic, the urgent need for clinical decision support tools led to the development of "COVID-gram," a risk score based on traditional logistic regression. While effective at identifying high-risk patients, static models often fail to capture the temporal dynamics of disease progression. Clinicians require more than a binary "yes/no" prediction; they need to understand the speed of deterioration to allocate limited resources effectively. This addendum details the evolution of the triage tool into a sophisticated deep-learning framework capable of time-dependent risk assessment.

Methodology

The transition from a linear Cox model to a deep-learning-based time-dependent model represents a significant methodological shift. The new framework integrates ten key prognostic factors: X-ray abnormalities, age, dyspnea, COPD, number of comorbidities, cancer history, neutrophil-to-lymphocyte ratio, lactate dehydrogenase (LDH), direct bilirubin, and creatine kinase.

A critical innovation is the inclusion of an automated missing-data imputation scheme. In emergency medical settings, clinical records are frequently incomplete. This scheme allows the model to remain robust and functional even when specific values are unavailable. Furthermore, the model supports dynamic monitoring by incorporating data from multiple time points post-admission, allowing for a continuously updated risk profile.

The study utilized an expanded dataset from the China National Health Commission. The training set comprised 1,590 cases from 31 provincial regions. The validation cohort was nearly doubled from the original 710 cases to 1,393 cases, incorporating updated data from the "Wuhan cohort" collected through late February 2020.

Results and Insights

The deep-learning model consistently outperformed traditional linear Cox models across various time intervals (e.g., 5, 10, and 30 days). The primary insight is that deep-learning architectures are inherently better at modeling the complex, non-linear relationships present in clinical data compared to traditional statistical methods.

By shifting the focus to time-dependent modeling, the researchers addressed the critical variable of "when" a patient might deteriorate. This temporal dimension is vital for hospital resource management. The validation results confirmed that the model maintained high performance even as the external dataset was significantly expanded.

Discussion and Limitations

The authors recommend the deep-learning model as the preferred tool for predicting the timing of critical illness or death. However, several limitations remain. The model was developed using data from the initial pandemic wave in China; its applicability to newer variants or different healthcare infrastructures requires further validation. Additionally, the "black box" nature of deep learning may pose a challenge for clinical adoption compared to simpler, point-based scoring systems.

Future work aims to implement this framework as a real-time bedside AI assistant, utilizing longitudinal data to provide continuous risk monitoring throughout a patient's hospital stay.

Summary updated

Abstract

The original Article did not reference our previous study 1 , which also presents a clinical prediction model for COVID-19 mortality/ critical illness risk. We wish to clarify the similarities and differences between the two studies in terms of cohort populations, methodology and clinical use.
BibTeX
@inproceedings{liang2021addendum,
  author = {Wenhua Liang and Jianhua Yao and Ailan Chen and Qingquan Lv and Mark Zanin and Jun Liu and Sook‐San Wong and Yimin Li and Jiatao Lu and Hengrui Liang and Guoqiang Chen and Haiyan Guo and Jun Guo and Rong Zhou and Limin Ou and Niyun Zhou and Hanbo Chen and Fan Yang and Xiao Han and Wenjing Huan and Weimin Tang and Wei‐jie Guan and Zisheng Chen and Yi Zhao and Ling Sang and Yuanda Xu and Wei Wang and Shiyue Li and Ligong Lu and Nuofu Zhang and Nanshan Zhong and Junzhou Huang and Jianxing He},
  title = {{Addendum: Early triage of critically ill COVID-19 patients using deep learning}},
  booktitle = {Nature Communications},
  year = {2021},
  doi = {10.1038/s41467-021-21044-3},
}
Figure